CRISPR, cystic fibrosis, drug development, gene editing, genetics, RNA editing

Biotech, drug discovery, gene editing, RNA coverage

Award-winning science journalist covering biotech, drug discovery, and gene editing based in Boston.

Genome editing and engineering including CRISPR/Cas9, TALENs, ZFNs, SynBio

Biotechnology, synthetic biology, solarpunk topics in scientific news

NIH and biomedical research policy coverage

Research and scientific content related to fluorescent reporter proteins

Experienced contributor and reporter with a background in health and science journalism, including roles at BioWorld and New Scientist.

Clinical development and manufacture of large molecule drugs news and analysis

Advanced tools in molecular biology research and molecular diagnostics

Reporter specializing in human pluripotent stem cells and skeletal muscle stem/progenitor cell research.

Science and business reporting focused on diagnostics and genomics

Science, medical, and genetic engineering content with biomedical engineering background

Precision medicine, health tech, and biotech coverage

Health and science reporting with focus on cellular and molecular medicine

Science journalism specializing in neuroscience for online publications

Biotechnology and pharmaceutical news and analysis

Science writing focused on molecular and cellular biology research content

Stories of providers and seekers on biopharma R&D and AI drug marketplaces

Genetics and scientific research editorial leadership at Nature Portfolio

Randall Mayes is a technology futurist, journalist, and author with a Master's from Duke University. He covers topics including AI, neuroscience, and synthetic biology. Experienced in technology and science journalism.

Experienced reporter and editor specializing in biotechnology and pharmacogenetics multimedia content.

Biopharma business news and industry issues for GEN and Clinical OMICs

Biotech and life sciences content and industry news

Trends in cognitive sciences and related editorial content

Focus on drug discovery and related scientific content

Synthetic biology, genetics, neuroscience coverage in top science publications

Daily news and features on the biotech space

Biopharma coverage and reporting focused on industry developments

Focus on bioengineering and related scientific content in Nature Reviews

Biotech and business technology investigative content and analysis